NFKB1 and neoplasm: Moreover, co-treatment with ATO and icariin resulted in a significant inhibition of tumor growth in xenograft murine model of Hep G2 compared to the treatment with either agent alone by promoting the generation of ROS and suppressing NF-κB without systemic toxicity [64].